Summary
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
TherapeuticsMD, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 8 | $44.72 | $15.76 | -$28.96 | -64.76% |
| RS Richard Sproll Tejara Capital Ltd. | 345,852 | $1.71M | $679,599.18 | -$1.03M | -60.21% |
| SE Sima Elimelech Activest Wealth Management | 40 | $64.4 | $77.6 | $13.2 | 20.5% |
 Leanne Menzel Smallwood Wealth Investment Management LLC | 2 | $1.86 | $3.82 | $1.96 | 105.38% |
 Christopher C. Powers Farther Finance Advisors, LLC | 31 | $31 | $63.86 | $32.86 | 106% |
TherapeuticsMD, Inc. (TXMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has TherapeuticsMD, Inc. ever had a stock split?
TherapeuticsMD, Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Marlan D. Walker CEO | NASDAQ (NGS) Exchange | 88338N206 CUSIP |
| US Country | 1 Employees | - Last Dividend | 9 May 2022 Last Split | 11 Dec 2003 IPO Date |
Overview
TherapeuticsMD, Inc. is a prominent pharmaceutical company based in the United States, specifically headquartered in Boca Raton, Florida. Founded in the year 2008, the company has carved a niche for itself in the pharmaceutical industry, principally focusing on the development and commercialization of innovative prescription pharmaceutical and prenatal vitamin products. It has entered into a significant license agreement with Mayne Pharma, empowering TherapeuticsMD to commercialize a unique range of products including IMVEXXY, BIJUVA, and ANNOVERA. Primarily catering to the wholesale distributors and retail pharmacy distributors, TherapeuticsMD has established itself as a key player in its domain, leveraging its strategic partnerships and extensive product range to meet the diverse needs of patients across the United States.
Products and Services
- IMVEXXY
IMVEXXY is a distinctive product from TherapeuticsMD's portfolio, designed to address specific health concerns. Its formulation is aimed at providing relief and therapeutic benefits, marking it as a crucial offering in their lineup. Through its distribution, IMVEXXY caters to a specific segment of the pharmaceutical market, reflecting the company's commitment to addressing niche healthcare needs.
- BIJUVA
BIJUVA represents another key product under TherapeuticsMD's umbrella, highlighting their focus on innovation and patient-centered solutions. This product is tailored to offer unique benefits, aligning with the company's vision of bringing forward pharmaceutical products that significantly improve patient outcomes. BIJUVA, like the rest of their products, is distributed through a network of wholesale and retail pharmacy distributors, ensuring broad accessibility.
- ANNOVERA
ANNOVERA stands out as a testament to TherapeuticsMD's continuous effort in pioneering healthcare solutions. Designed with precision, ANNOVERA is geared towards meeting the evolving needs of patients, thereby solidifying the company's position in the pharmaceutical sector. Its contribution to the company's product line is significant, underpinning TherapeuticsMD's role in leading through innovation.
- Prenatal Vitamin Products
The BocaGreenMD and vitaMedMD brands under TherapeuticsMD encapsulate a range of prescription prenatal vitamin products, addressing the critical nutritional needs during pregnancy. These brands are a reflection of TherapeuticsMD’s commitment to maternal and fetal health, providing comprehensive nutritional support through scientifically-formulated products. Distributed widely, these prenatal vitamins play a pivotal role in the company's mission to enhance healthcare outcomes.
